Live long and PROSPER: enzalutamide for nmCRPC

There has previously been no approved treatment for nonmetastatic castration-resistant prostate cancer (nmCRPC), due to a lack of evidence that any drug would prevent disease progression in this popul... Author: VJOncology Added: 02/16/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts